GE Aerospace is the IBD Stock Of The Day as it vows to invest nearly $1 billion in its U.S. factories and supply chain. On ...

TRV stock is in a base with a buy point of 269.56. The blue dot on IBD MarketSurge shows that its relative strength line is at a new high. Health Care Stocks. A few biotechs are a ...

Dual biologic therapy may serve as a suitable treatment choice for patients with IBD who have not responded to current therapies.

Johnson & Johnson and Protagonist Therapeutics have bet their oral IL-23 drug will be an immunology blockbuster, and they are ...

Achieving cost sustainability in inflammatory bowel disease (IBD) care requires expanding access to cost-effective treatments ...

A team of researchers has unveiled a revolutionary ingestible bioimpedance sensing device capable of continuously and ...

For patients with inflammatory bowel disease (IBD), risk factors associated with Clostridioides difficile infection (CDI) include recent diagnosis, corticosteroid usage, and hospitalization.

For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...

Teva's business is encountering headwinds, including declining U.S. generics revenue. Read what this biotech plans to do in ...

Mental health comorbidities are more prevalent among transgender and gender nonconforming adults with IBD than the general and IBD US populations.

Action Sports Jax’s Stuart Webber will be emceeing the Crohn’s & Colitis Take Steps! walk on Saturday, April 12.